Antiviral Biopharma

Gilead Sciences

Gilead Sciences is a research-focused biopharmaceutical company headquartered in Foster City, California, that discovers, develops, and commercialises medicines in areas of unmet medical need. Its most celebrated scientific contributions include breakthrough antiretroviral therapies that transformed HIV/AIDS from a fatal illness to a manageable chronic condition, as well as the nucleotide analog remdesivir used against RNA viruses including SARS-CoV-2. Gilead invests heavily in academic partnerships, funding collaborative research programmes at universities and research hospitals globally. Scientists benefit from access to Gilead's compound libraries, co-authorship on peer-reviewed publications, and sponsored post-doctoral fellowships. The company's pipeline spans antiviral, oncology, and inflammatory-disease programmes, making it a valued partner for immunologists, virologists, and cancer biologists seeking translational opportunities.